ATE417930T1 - Proteinkinase npk-110 - Google Patents
Proteinkinase npk-110Info
- Publication number
- ATE417930T1 ATE417930T1 AT95937855T AT95937855T ATE417930T1 AT E417930 T1 ATE417930 T1 AT E417930T1 AT 95937855 T AT95937855 T AT 95937855T AT 95937855 T AT95937855 T AT 95937855T AT E417930 T1 ATE417930 T1 AT E417930T1
- Authority
- AT
- Austria
- Prior art keywords
- protein kinase
- npk
- alzheimer
- maps
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94117122 | 1994-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE417930T1 true ATE417930T1 (de) | 2009-01-15 |
Family
ID=8216419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95937855T ATE417930T1 (de) | 1994-10-28 | 1995-10-30 | Proteinkinase npk-110 |
Country Status (12)
Country | Link |
---|---|
US (2) | US6579691B1 (de) |
EP (1) | EP0791067B1 (de) |
JP (1) | JPH10508199A (de) |
KR (1) | KR100275591B1 (de) |
CN (1) | CN1168699A (de) |
AT (1) | ATE417930T1 (de) |
CA (1) | CA2203910A1 (de) |
DE (1) | DE69535901D1 (de) |
HU (1) | HUT77081A (de) |
NO (1) | NO971966L (de) |
NZ (1) | NZ295371A (de) |
WO (1) | WO1996013592A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69233736D1 (de) * | 1991-12-06 | 2008-07-24 | Max Planck Gesellschaft | Phosphorylierungsepitope aus dem Tau-Protein zur Diagnose und Behandlung der Alzheimer-Krankheit |
AU6421498A (en) * | 1997-04-28 | 1998-11-24 | Helix Research Institute | Serine/threonine protein kinase |
EP1294896A2 (de) * | 2000-04-25 | 2003-03-26 | Millennium Pharmaceuticals, Inc. | 13295 proteinkinase moleküle und deren verwendung |
AU2002239571A1 (en) * | 2000-12-06 | 2002-06-18 | Incyte Genomics, Inc. | Kinases and phosphatases sequences, and use thereof |
US7119185B2 (en) * | 2000-12-21 | 2006-10-10 | Trustees Of The University Of Pennsylvania | Hormonally up-regulated, neu-tumor-associated kinase |
WO2002067764A2 (en) * | 2001-02-27 | 2002-09-06 | Blanchette Rockefeller Neurosciences Institute | Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
CA2449289A1 (en) | 2001-06-05 | 2002-12-12 | Exelixis, Inc. | Gfats as modifiers of the p53 pathway and methods of use |
US6492156B1 (en) * | 2001-10-31 | 2002-12-10 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
WO2005010148A2 (en) * | 2003-06-19 | 2005-02-03 | Exelixis, Inc. | Marks as modifiers of the pten pathway and methods of use |
US8273536B2 (en) | 2003-06-19 | 2012-09-25 | Exelixis, Inc. | Marks as modifers of the PTEN pathway and methods of use |
CN100424184C (zh) * | 2005-12-09 | 2008-10-08 | 浙江大学 | 疱疹类病毒基因芯片及其应用 |
US9433922B2 (en) * | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
KR101294725B1 (ko) * | 2010-12-30 | 2013-08-08 | 연세대학교 산학협력단 | 인산화된 grasp를 포함하는 낭포성섬유증 치료용 약학 조성물 |
US9518101B2 (en) * | 2011-09-19 | 2016-12-13 | Axon Neuroscience Se | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
CN117551674A (zh) * | 2023-11-20 | 2024-02-13 | 内蒙古农业大学 | 沙葱萤叶甲微管亲和调节激酶GdMARK2基因的克隆及其功能 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544942A1 (de) * | 1991-12-06 | 1993-06-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Neue Werkzeuge für die Diagnose und die Behandlung der Alzheimer-Krankheit |
-
1995
- 1995-10-30 CN CN95196569A patent/CN1168699A/zh active Pending
- 1995-10-30 KR KR1019970702885A patent/KR100275591B1/ko not_active IP Right Cessation
- 1995-10-30 NZ NZ295371A patent/NZ295371A/en unknown
- 1995-10-30 WO PCT/EP1995/004258 patent/WO1996013592A2/en active IP Right Grant
- 1995-10-30 HU HU9702175A patent/HUT77081A/hu unknown
- 1995-10-30 CA CA002203910A patent/CA2203910A1/en not_active Abandoned
- 1995-10-30 EP EP95937855A patent/EP0791067B1/de not_active Expired - Lifetime
- 1995-10-30 DE DE69535901T patent/DE69535901D1/de not_active Expired - Lifetime
- 1995-10-30 US US08/817,832 patent/US6579691B1/en not_active Expired - Fee Related
- 1995-10-30 JP JP8514323A patent/JPH10508199A/ja not_active Ceased
- 1995-10-30 AT AT95937855T patent/ATE417930T1/de not_active IP Right Cessation
-
1997
- 1997-04-28 NO NO971966A patent/NO971966L/no not_active Application Discontinuation
-
2003
- 2003-05-16 US US10/440,435 patent/US7485712B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1996013592A2 (en) | 1996-05-09 |
AU714636B2 (en) | 2000-01-06 |
EP0791067A2 (de) | 1997-08-27 |
EP0791067B1 (de) | 2008-12-17 |
NO971966L (no) | 1997-06-19 |
HUT77081A (hu) | 1998-03-02 |
CN1168699A (zh) | 1997-12-24 |
NO971966D0 (no) | 1997-04-28 |
AU3870295A (en) | 1996-05-23 |
MX9703101A (es) | 1998-07-31 |
CA2203910A1 (en) | 1996-05-09 |
KR100275591B1 (ko) | 2001-02-01 |
DE69535901D1 (de) | 2009-01-29 |
US20030104516A1 (en) | 2003-06-05 |
NZ295371A (en) | 1998-11-25 |
US7485712B2 (en) | 2009-02-03 |
US20040038361A1 (en) | 2004-02-26 |
WO1996013592A3 (en) | 1996-08-01 |
US6579691B1 (en) | 2003-06-17 |
JPH10508199A (ja) | 1998-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69535901D1 (de) | Proteinkinase npk-110 | |
AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
EP0683234A4 (de) | ANTIKÖRPER GEGEN -g(b)-AMYLOID ODER DERIVATE DAVON UND SEINE VERWENDUNG. | |
HK1027820A1 (en) | Molecules that home to a selected organ or tissue in vivo | |
EP0909814A3 (de) | Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit | |
AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
FI925986A0 (fi) | Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det | |
PT737207E (pt) | Inibidores de plasmina humana derivados de dominios kunitz | |
MX9709913A (es) | Metaloconstrucciones determinadas estructuralmente y aplicaciones. | |
WO2002057259A3 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
DE69435038D1 (de) | Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie | |
EA200101037A1 (ru) | Соединения и способы для лечения и диагностики рака легкого | |
ATE418563T1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
ATE212065T1 (de) | Nukleinsäuremoleküle mit der fähigkeit zur unterscheidung von prpc und prpsc-prionprotein- isoformen und verfahren zu deren herstellung | |
WO2003028543A3 (en) | Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
WO2002046767A3 (en) | Diagnosis and treatment of alzheimer's disease | |
WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
DE69728897D1 (de) | Saeugetierchemokine | |
ATE266731T1 (de) | Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung | |
HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
ATE219247T1 (de) | Methoden zur feststellung von alzheimerscher krankheit | |
WO2001064876A3 (en) | Human schizophrenia gene | |
EP0780472A3 (de) | Stress Proteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |